USP7-IN-1 is a selective, reversible inhibitor of ubiquitin-specific protease 7 (USP7) with a reported IC50 of 77 µM. This compound is a valuable research tool for investigating USP7s role in oncology and neurodegenerative disease pathways in cellular and biochemical assays.